The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 15,684 | 30,952 |
| Accretion of net discounts and deferred loan fees | 5,156 | 11,718 |
| Depreciation on premises and equipment | 416 | 1,006 |
| Intangible asset amortization | 948 | 1,896 |
| Amortization of discounts on debt securities | -453 | -508 |
| Gain on sale of loans | 0 | 577 |
| Loss on sale and disposal of fixed assets | 0 | -1 |
| Loans originated for sale | 0 | 8,955 |
| Proceeds from sales of and principal collected on loans held for sale | 0 | 9,569 |
| (reversal of) provision for credit losses | -15 | -4,410 |
| Deferred income tax expense (benefit) | 819 | 7,952 |
| Stock-based compensation | 1,461 | 3,005 |
| Income from bank owned life insurance | 883 | 966 |
| Loss on sale of other real estate owned | 0 | -862 |
| Valuation allowance on other real estate owned | 0 | - |
| Net change in other items | -3,156 | 7,704 |
| Net cash provided by operating activities | 15,977 | 20,405 |
| Net cash acquired in business combination | 0 | - |
| Proceeds from bank owned life insurance death benefits | 0 | 1,572 |
| Proceeds from sale of debt securities available for sale | 0 | - |
| Proceeds from maturities and paydowns of debt securities available for sale | 7,270 | 24,379 |
| Purchases of debt securities available for sale | 25,580 | 65,735 |
| Net change in stock investments | - | 779 |
| Net change in restricted stock and other equity securities | 729 | - |
| Net repayment of loans | -5,781 | -152,904 |
| Proceeds from sale of loans held for investment | 0 | 13,500 |
| Proceeds from sale of other real estate owned | 0 | 1,421 |
| Purchases of premises and equipment | 108 | 139 |
| Net cash provided by investing activities | -12,587 | 127,123 |
| Repayment of other borrowings | - | 18,000 |
| Net increase in deposits | 147,383 | -86,444 |
| Repayment of federal home loan bank advances | 0 | 0 |
| Repayment of borrowings | 38,000 | - |
| Proceeds from exercise of stock options | 31 | 101 |
| Repurchase of common shares | 1,725 | 1,210 |
| Net cash provided by financing activities | 125,689 | -105,553 |
| Net change in cash and cash equivalents | 129,079 | 41,975 |
| Cash and cash equivalents at beginning of period | 388,162 | - |
| Cash and cash equivalents at end of period | 559,216 | - |
California BanCorp CA (BCAL)
California BanCorp CA (BCAL)